AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.
Breast surgery
Communication
Early breast cancer
Postneoadjuvant therapy
Radiotherapy
Reconstruction
Journal
Breast care (Basel, Switzerland)
ISSN: 1661-3791
Titre abrégé: Breast Care (Basel)
Pays: Switzerland
ID NLM: 101254060
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
30
04
2022
accepted:
30
04
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
ppublish
Résumé
The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer as an interdisciplinary team consists of specialists from gynecological oncology, pathology, diagnostic radiology, medical oncology, and radiation oncology with a special focus on breast cancer. The updated evidence-based treatment recommendation 2022 for early breast cancer (EBC) and metastatic breast cancer of the AGO Task Force has been released. This paper captures the update of EBC.
Identifiants
pubmed: 36156915
doi: 10.1159/000524879
pii: brc-0017-0403
pmc: PMC9453658
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
403-420Informations de copyright
Copyright © 2022 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
Prof. Dr. med. Nina Ditsch; Advisory Board: AstraZeneca, Daiichi-Sankyo, Lilly, Lukon, Molekular Health, MSD, Novartis, Gilead Sciences, onkowissen, Pfizer, Roche, Seagen; Lecture: Novartis, Pfizer, MSD. Prof. Dr. med. Achim Wöckel; Advisory board: Amgen, AstraZeneca, Aurikamed, Celgene, Eisai, Lilly, Novartis, Pfizer, Roche, Tesaro, Sirtex, MSD, Genomic Health, Pierre Fabre, Clovis, Organon. Prof. Dr. med. Christian Jackisch; Advisory board: Exact Sciences, Pfizer, Roche, GSK, Pierre-Fabre, Seagen; Lecture: AstraZeneca, Lilly, Novartis, Roche, Novartis, Amgen, Pierre-Fabre, Exact Sciences, MSD. Prof. Dr. med. Michael Untch; Advisory board: Lilly, AstraZeneca, Pfizer, Roche, Pierre Fabre, Sanofi Aventis, Gilead Science; Lecture: Daiichi Sankyo, Lilly, Seagen, Novartis, AstraZeneca, Roche, Eisai, MSD, I-Med_Insitute, Onkowissen, art tempi, High5Med. Prof. Dr. med. Ute-Susann Albert; Lectures and/or consulting: Pfizer, Novartis, Aurikamed. PD Dr. Malgorzata Banys-Paluchowski; Advisory board: Novartis, Roche, LIlly, Pfizer, GSK, MSD. Lecture: Novartis, Pfizer, pfm medical, Seagen, Daiichi Sankyo, Lilly, Roche, Amgen; Trial funding: Mammotome, Exact Sciences, Merit Medical, Endomag. Dr. med. Ingo Bauerfeind; No conflicts of interest. Prof. Dr. med. Jens-Uwe Blohmer; Honoraria: Astrazeneca, Eisai, Lilly, MSD, Novartis, Pfizer, Roche, Seagen. Prof. Dr. med. Wilfried Budach; Lecture: Merck, medpublico GmbH, BVDST. Prof. Dr. med. Peter Dall; Advisory Boards: Gilead Science, Roche; Lecture: Novartis, AstraZeneca, Pfizer. PD Dr. med. Eva Maria Fallenberg; No conflicts of interest. Prof. Dr. med. Peter A. Fasching; Advisory board: Pfizer, Novartis, Roche, Daiichi Sankyo, Eisai, AstraZeneca, Lilly, MSD, Seagen, Agendia, Pierre Fabre, Sanofi Aventis, Gilead Science; Lecture: Pfizer, Novartis, Roche, Daiichi Sankyo, Eisai, AstraZeneca, Lilly, MSD, Seagen, Gilead Sciences; Other: Onkowissen, art tempi. Prof. Dr. med. Tanja N. Fehm; Onkowissen. Prof. Dr. med. Michael Friedrich; Advisory Board: Gilead Sciences; Other honoraria: Roche, MSD; Stockholding: Biontech, Curevac. Prof. Dr. med. Bernd Gerber; Lecture honoraria: Roche, AstraZeneca, Seagen, Novartis, Pfizer, MedConcept; Others: Pfizer. PD Dr. med. Oleg Gluz; No conflicts of interest. Prof. Dr. med. Nadia Harbeck; Honoraria for lectures and/or consulting: Amgen, AstraZeneca, Daiichi Sanyko, Gilead Science, Lilly, MSD, Novartis, Pierre-Fabre, Pfizer, Roche, Sandoz, Seagen, Exact Sciences; Minority share holder: Westdeutsche Studiengruppe (WSG). Prof. Dr. med. Jörg Heil; Advisory board: Polytech; Trial funding: pfm medical. Prof. Dr. med. Jens Huober; Lecture: Giled Science, Seagen, Lilly, Novartis, Daiichi Sankyo, GSK, Pfizer. Prof. Dr. med. Hans-Heinrich Kreipe; Advisory board: Lilly; Lecture: AstraZeneca, Roche, Daiichi Sankyo, Pfizer. Dr. David Krug; Lecture: MSD, ESO, ESMO, medupdate GmbH; Trial funding: Merck. Prof. Dr. med. Thorsten Kühn, Advisory Board: Sysmex, Neodynamics; Trial funding: Merit Medical, Endomag, Mammotome; Lecture: Pfizer. Prof. Dr. med. Sherko Kümmel; Lecture: Roche, Lilly, Exact Sciences, Novartis, Amgen, Daiichi Sankyo, AstraZeneca, Somatex, MSD, Pfizer, pfm medical, Seagen, Gilead Science, Agendia; Other honoraria: Roche, Daiichi Sankyo, Sonoscape; Advisory board: Lilly, MSD, Roche. Prof. Dr. med. Cornelia Kolberg-Liedtke; Advisory board: Aurikamed, Novartis, Pfizer, MSD, Novartis, Gilead Science, Seagen, Lilly, Agendia, Daiichi Sankyo; Lecture: Roche, Novartis, Pfizer, Exact Sciences, Amgen, AstraZeneca, Carl Zeiss Meditec, NCO Hannover; Other: Gilead Science, POMME; Stockholding: Phaon Scientific; Trial Funding: Gilead Science. Prof. Dr. med. Sibylle Loibl; Trial funding: Abbvie, AstraZeneca, Celgene, Daiichi Sankyo, Gilead Science, Novartis, Pfizer, Roche; Lecture: Abbvie, Amgen, AstraZeneca, Bayer, BMS, Celgene, Daiichi Sankyo, Eirgenix, GSK, Gilead Science, Lilly, Merck, Novartis, Pfizer, Pierre Fabre, Prime/Medscape, Puma, Roche, Samsung. Prof. Dr. med. Michael Patrick Lux; Lecture: Lilly, Roche, MSD, Onkowissen, Novartis, Pfizer, Exact Sciences, Daiichi Sankyo, Gilead, Grünenthal, Eisai, AstraZeneca; Advisory board: pfm medical, Saman Tree, Sysmex, Lilly, AstraZeneca, MSD, Novartis, Pfizer, Eisai, Gilead, Exact Sciences, Daiichi Sankyo, Grünenthal, Pierre fabre, PharmaMar, Roche; Other: Medac, Pfizer. Prof. Dr. med. Nicolai Maass; Advisory board: Amgen, Grünenthal. Lecture: AstraZeneca, Pierre Fabre, Clovis, Seagen, Lilly, MSD, Novartis, Pfizer. Prof. Dr. med. Christoph Mundhenke; Not specified. Prof. Dr. med. Ulrike Nitz; Not specified. Prof. Dr. Tjoung-Won Park-Simon; Advisory board: Roche, AstraZeneca, GSK, Pfizer, Lilly, MSD, Exact Sciences, Daiichi Sankyo, Seagen, Novartis, Gilead Science; Lecture: Roche, AstraZeneca, GSK, Pfizer, Lilly, MSD, NCO, Exact Sciences, Daiichi Sankyo, Seagen, Novartis, Gilead Science. Prof. Dr. med. Toralf Reimer; Trial funding: Novartis, German Cancer Aid and Else Kroener-Fresenius-Stiftung; Advisory board: MSD, Novartis, Myriad; Lecture: Pfizer, Novartis, Roche, AstraZeneca. PD. Dr. med. Kerstin Rhiem; Lecture: AstraZeneca, Amgen, MDS, Medupdate, Medconcept. Prof. Dr. med. Achim Rody; Advisory board: AstraZeneca, Novartis, Roche, Exact Sciences, Pierre Fabre, Lilly, Seagen, Amgen, MSD; Lecture: Pfizer, Celgene, Eisai; Trial funding: Eisai. Prof. Dr. med. Marcus Schmidt; Advisory board: AstraZeneca, Novartis, Eisai, Lilly, MSD, Pierre Fabre, Pfizer, Roche, Seagen. Prof. Dr. med. Andreas Schneeweiss; Lecture: Amgen, AstraZeneca, Aurikamed, Clinsol, ConnectMedica, Gilead Science, GSK, I-Med, Lilly, MSD, Nanostring, Novartis, Onkowissen, Promedicis, Pfizer, Pierre Fabre, Roche, Seagen, StreamedUp; Other: Thieme. Prof. Dr. med. Florian Schütz; Lecture: Amgen, AstraZeneca, Eisai, Pfizer, Novartis, Onkowissen; Advisory board: Amgen, Lilly, MSD, Eisai. Prof. Dr. med. Hans-Peter Sinn; Advisory board: Diaceutics. Prof. Dr. med. Christine Solbach; Lecture: DiaLog Service GmbH, Jörg Eickeler, Pfizer, MedConcept, Medicultus, GBG, Dt. Röntgengesellschaft, BVF Akademie, LÄK Hessen Akademie, Meet the Expert Academy; Advisory board: MSD, Roche. Prof. Dr. med. Erich-Franz Solomayer; Lecture: Universitätsklinikum Freiburg, MedConcept, Saarländische Krebsgesellschaft, Bsh medical Communications GmbH, Pfizer, AstraZeneca; Other: Roche, Amgen, Clovis, AstraZeneca, Novartis, GSK, MSD, Eisai, Pfizer, Medac, Pierre Fabre, PharmaMar, Daiichi Sankyo, Samsung, Primus, matramed, GE Healthcare; Trial funding: Medac, GBG, AMS, AstraZeneca, Pfizer, Novartis, AGO Research GmbH, WSG, Universitätsklinikum Tübingen, Roche. Prof. Dr. med. Elmar Stickeler; Advisory boards: Gilead, Iomedico, Lilly, MSD, Seagen; Lecture: Pfizer, Bsh Düsseldorf, Gilead, Iomedico, PharmaMar, Onkowissen, Roche. Prof. Dr. med. Christoph Thomssen; Advisory board: Amgen, AstraZeneca, Hexal, Lilly, MSD, Pfizer, Roche, Seagen; Lecture: Klnikum Wolfsburg, Medicultus, Medupdate, Novartis, Pfizer, Roche, AstraZeneca, Daiichi Sankyo, Jörg Eickeler, Evang. KH Wittenberg, Gilead Science: Other: Aurikamed, ForumSanitas/Merit Corporate, Onkowissen, Pfizer, Daiichi Sankyo. Prof. Dr. Isabell Witzel; Lecture: Daiichi Sankyo, Pfizer, MSD, Lilly, Seagen, AstraZeneca; Other: Onkowissen; Prof. Dr. med. Volkmar Müller; Lecture: Amgen, AstraZeneca, Daiichi Sankyo, eisai, GSK, Pfizer, MSD, Medac, Novartis, Roche, Teva, Seagen, Onkowissen, High5Oncology, Medscape, Gilead; Advisory board: Hexal, Roche, Pierre Fabre, Amgen, Clinsol, Novartis, MSD, Daiichi Sankyo, Eisai, Lilly, Sanofi Aventis, Seagen, Gilead Science; Trial funding: Novartis, Roche, Seagen, Genetech; Other: Daiichi Sankyo. Prof. Dr. med. Wolfgang Janni; Lecture: Amgen, AstraZeneca, Daiichi Sankyo, Lilly, MSD, Novartis, Pfizer, Roche, Seagen, Gilead Science; Trial Funding: Amgen, AstraZeneca, Lilly, Novartis, Roche. Prof. Dr. med. Marc Thill; Advisory boards: Agendia, Amgen, AstraZeneca, Aurikamed, Becton and Dickinson, ClearCut, Clovis, Daiichi Sankyo, Eisai, Exact Sciences, Gilead Science, Grünenthal, GSK, Lilly, MSD, Neodynamics, Novartis, Onkowissen, Organon, Pfizer, pfm Medical, Pierre-Fabre, Roche, Seagen, Sirius Pintuition, Sysmex; Manuscript support: Amgen, Clearcut, Clovis, pfm medical, Roche, Servier; Travel reimbursement: Amgen, art tempi, AstraZeneca, Clovis, Connect Medica, Daiichi Sankyo, Eisai, Exact Sciences, Lilly, MSD, Novartis, Pfizer, pfm Medical, Roche, Seagen; Congress support: Amgen, AstraZeneca, Daiichi Sanyko, Novartis, Pfizer, Roche; Lecture: Amgen, art tempi, AstraZeneca, Clovis, Connect Medica, Daiichi Sankyo, Exact Sciences, Gilead Science, Hexal, I-Med-Institute, Jörg Eickeler, Lilly, MSD, Novartis, Onkowissen, Pfizer, pfm medical, Roche, Seagen, Sysmex, Vifor, Viatris, Trial funding: Endomagnetics, Exact Sciences. We have no acknowledgements for this article.
Références
J Clin Oncol. 2016 Apr 1;34(10):1072-8
pubmed: 26811528
Eur Radiol. 2020 Apr;30(4):2058-2071
pubmed: 31900699
NPJ Breast Cancer. 2021 Jul 22;7(1):96
pubmed: 34294707
J Clin Oncol. 2021 May 10;39(14):1518-1530
pubmed: 33793299
Breast Cancer Res Treat. 2019 Apr;174(2):279-296
pubmed: 30506111
J Clin Oncol. 2019 Jul 1;37(19):1629-1637
pubmed: 30973790
J Pathol. 2015 Oct;237(2):179-89
pubmed: 26095796
Am J Surg. 2021 Oct;222(4):715-722
pubmed: 33771341
Clin Sarcoma Res. 2017 Aug 7;7:15
pubmed: 28794852
Regul Toxicol Pharmacol. 2021 Oct;125:104982
pubmed: 34214611
J Clin Oncol. 2022 Mar 1;40(7):787-800
pubmed: 35041467
J Clin Oncol. 2022 Jan 20;40(3):282-293
pubmed: 34874182
Ann Oncol. 2021 Aug;32(8):1005-1014
pubmed: 33932503
J Plast Reconstr Aesthet Surg. 2020 Apr;73(4):651-662
pubmed: 31926896
Lancet. 2019 Apr 6;393(10179):1440-1452
pubmed: 30739743
Cancer Biol Med. 2022 Feb 16;:
pubmed: 35170879
J Clin Oncol. 2021 Aug 10;39(23):2564-2573
pubmed: 34101481
Cochrane Database Syst Rev. 2018 Jan 29;1:CD011292
pubmed: 29376559
Ann Oncol. 2022 Apr;33(4):384-394
pubmed: 35093516
Int J Cancer. 2021 Nov 15;149(10):1828-1832
pubmed: 34270809
Lancet Oncol. 2021 Feb;22(2):212-222
pubmed: 33460574
Lancet Oncol. 2020 Aug;21(8):e375-e385
pubmed: 32758475
J Clin Oncol. 2011 May 20;29(15):1956-62
pubmed: 21482989
Data Brief. 2021 Sep 10;38:107354
pubmed: 34557571
Anticancer Drugs. 2022 Jan 1;33(1):e52-e60
pubmed: 34371505
Strahlenther Onkol. 2021 Apr;197(4):269-280
pubmed: 33507331
Radiology. 2022 Mar;302(3):568-581
pubmed: 34904875
Ann Intern Med. 2020 Jan 7;172(1):46-56
pubmed: 31766052
JAMA Oncol. 2020 Sep 1;6(9):1390-1396
pubmed: 32789480
J Clin Oncol. 2018 May 1;36(13):1317-1322
pubmed: 29558281
Ann Surg. 2021 Mar 1;273(3):449-458
pubmed: 33234792
N Engl J Med. 2021 Feb 4;384(5):428-439
pubmed: 33471991
N Engl J Med. 2022 Feb 10;386(6):556-567
pubmed: 35139274
J Plast Surg Hand Surg. 2018 Jun;52(3):130-147
pubmed: 29320921
Ann Surg Oncol. 2021 Oct;28(10):5610-5616
pubmed: 34426884
Cancers (Basel). 2021 Dec 03;13(23):
pubmed: 34885211
Support Care Cancer. 2019 May;27(5):1879-1889
pubmed: 30194492
Cancer Epidemiol. 2021 Dec;75:102050
pubmed: 34706325
Clin Imaging. 2022 Feb;82:179-192
pubmed: 34872008
J Pathol. 2012 Jan;226(1):84-96
pubmed: 22015727
JAMA. 2018 Jul 10;320(2):167-176
pubmed: 29998338
Breast Cancer. 2021 May;28(3):618-629
pubmed: 33387284
Am J Surg Pathol. 2016 Aug;40(8):1109-16
pubmed: 27259012
J Clin Oncol. 2020 Nov 1;38(31):3698-3715
pubmed: 32716741
JAMA Oncol. 2021 Dec 01;7(12):1851-1855
pubmed: 34617979
Ann Oncol. 2020 Feb;31(2):171-190
pubmed: 31959335
Eur J Cancer. 2021 May;148:159-170
pubmed: 33743484
Adv Radiat Oncol. 2020 Nov 01;6(2):100607
pubmed: 33912731
Eur J Cancer. 2016 Jan;53:65-74
pubmed: 26693900
Eur Radiol. 2022 Apr;32(4):2301-2312
pubmed: 34694451
JAMA Oncol. 2021 Aug 01;7(8):1149-1157
pubmed: 34165508
Breast. 2020 Oct;53:138-142
pubmed: 32795829
Eur J Radiol. 2020 Jan;122:108766
pubmed: 31809942
Eur J Surg Oncol. 2022 Jan;48(1):53-59
pubmed: 34656392
J Clin Med. 2021 Jan 04;10(1):
pubmed: 33406802
BMC Cancer. 2021 Oct 15;21(1):1109
pubmed: 34654387
Clin Breast Cancer. 2021 Aug;21(4):278-291
pubmed: 33846098
Strahlenther Onkol. 2020 Sep;196(9):749-763
pubmed: 32350554
Am J Surg Pathol. 2015 Nov;39(11):1458-67
pubmed: 26291510
Cancers (Basel). 2021 Mar 29;13(7):
pubmed: 33805367
Plast Reconstr Surg. 2021 May 1;147(5S):7S-13S
pubmed: 33890875
J Natl Compr Canc Netw. 2021 May 01;19(5):484-493
pubmed: 34794122
Plast Reconstr Surg Glob Open. 2020 Jan 27;8(1):e2613
pubmed: 32095414
Radiology. 2021 May;299(2):278-286
pubmed: 33724062
Korean J Radiol. 2021 Aug;22(8):1240-1252
pubmed: 34047504
Ann Oncol. 2020 Dec;31(12):1650-1663
pubmed: 32801018
J Cell Immunol. 2020 May;2(3):80-89
pubmed: 32914146
Histopathology. 2018 Aug;73(2):339-344
pubmed: 29603332
Breast Cancer Res Treat. 2017 Aug;165(1):139-149
pubmed: 28578506
N Engl J Med. 2019 Feb 14;380(7):617-628
pubmed: 30516102
CA Cancer J Clin. 2016 Jan-Feb;66(1):43-73
pubmed: 26641959
Radiology. 2022 Feb;302(2):246-255
pubmed: 34931856
Ann Oncol. 2021 Dec;32(12):1571-1581
pubmed: 34656740
Ann Surg Oncol. 2021 Oct;28(10):5461-5467
pubmed: 34346020
NPJ Breast Cancer. 2021 Aug 2;7(1):101
pubmed: 34341356
Genet Med. 2021 Aug;23(8):1416-1423
pubmed: 33976419
Breast J. 2020 Feb;26(2):261-264
pubmed: 31538375
Radiol Imaging Cancer. 2021 Jan 22;3(1):e200116
pubmed: 33778758
Nat Commun. 2020 Jun 23;11(1):3083
pubmed: 32576828
J Res Health Sci. 2021 Jul 20;21(3):e00520
pubmed: 34698654
Ann Surg Oncol. 2021 Feb;28(2):968-974
pubmed: 32813202
Breast J. 2018 May;24(3):350-355
pubmed: 28845569
J Natl Cancer Inst. 2021 Jun 1;113(6):680-690
pubmed: 33372954
J Clin Med. 2021 Apr 06;10(7):
pubmed: 33917590
Am J Clin Oncol. 2016 Jun;39(3):314-9
pubmed: 27203824
Eur Radiol. 2021 Aug;31(8):5880-5893
pubmed: 34052881
Lasers Med Sci. 2020 Feb;35(1):1-11
pubmed: 31396795
Breast Cancer Res Treat. 2021 Feb;186(1):219-227
pubmed: 33150548
Lancet. 2011 Aug 27;378(9793):771-84
pubmed: 21802721
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848
Clin Breast Cancer. 2021 Dec;21(6):552-565
pubmed: 33741292
Lancet Oncol. 2022 Mar;23(3):382-392
pubmed: 35123662
JAMA Oncol. 2021 Apr 01;7(4):565-572
pubmed: 33538790